Yaming Wei
Impact in
-
- Mesenchymal stem cell research
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 3
- Oncology 7
- Co-authors
- Zhaohu Yuan (12 shared papers)Rongliang Zheng (6 shared papers)Xiaojie Chen (5 shared papers)Zhong‐Jian Jia (2 shared papers)Weijie Zhong (4 shared papers)Fangxin Zhang (1 shared paper)Huabao Xiong (2 shared papers)Xin Xu (2 shared papers)
- Journals
- Stem Cell Research & Therapy (3 papers)Frontiers in Oncology (2 papers)Transfusion (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Mutation Research/Genetic Toxicology and Environmental Mutagenesis (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yaming Wei
35 papers receiving 384 citations
Peers
Comparison fields: 5 of 80
- Genetics 65
- Cancer Research 67
- Oncology 97
- Nutrition and Dietetics 43
- Microbiology 2
Countries citing papers authored by Yaming Wei
This map shows the geographic impact of Yaming Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaming Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaming Wei more than expected).
Fields of papers citing papers by Yaming Wei
This network shows the impact of papers produced by Yaming Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaming Wei. The network helps show where Yaming Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yaming Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 42 | |
| 2 | 2002 | 41 | |
| 3 | 2009 | 32 | |
| 4 | 2015 | 32 | |
| 5 | 2019 | 31 | |
| 6 | 2015 | 28 | |
| 7 | 2017 | 27 | |
| 8 | 2018 | 23 | |
| 9 | 2020 | 14 | |
| 10 | 2018 | 14 | |
| 11 | 2016 | 13 | |
| 12 | Effects of diethyldithiocarbamate on proliferation, redifferention, and apoptosis in human hepatoma cells. | 2001 | 12 |
| 13 | Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines. | 2019 | 9 |
| 14 | 2018 | 8 | |
| 15 | 2020 | 8 | |
| 16 | 2004 | 7 | |
| 17 | Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines. | 2001 | 7 |
| 18 | 2008 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2020 | 4 |
About Yaming Wei
Yaming Wei is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Cancer Research, having authored 38 papers that have together received 391 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers), MicroRNA in disease regulation (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Cancer-related molecular mechanisms research (4 papers), Mesenchymal stem cell research (3 papers), Virus-based gene therapy research (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Genetics (65 citations), Cancer Research (67 citations), Oncology (97 citations), Nutrition and Dietetics (43 citations) and Microbiology (2 citations). Yaming Wei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhaohu Yuan, Rongliang Zheng, Xiaojie Chen, Zhong‐Jian Jia, Weijie Zhong, Fangxin Zhang, Huabao Xiong, Xin Xu, Yuqiang Nie and Yu‐Jui Yvonne Wan. Their work appears in journals such as Stem Cell Research & Therapy, Frontiers in Oncology, Transfusion, International Journal of Radiation Oncology*Biology*Physics and Mutation Research/Genetic Toxicology and Environmental Mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.